These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14742198)

  • 1. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.
    Stone GW; Zhang Q; Castillo R; Doppalapudi VR; Bueno AR; Lee JY; Li Q; Sergeeva M; Khambatta G; Georgopapadakou NH
    Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains.
    Li Q; Lee JY; Castillo R; Hixon MS; Pujol C; Doppalapudi VR; Shepard HM; Wahl GM; Lobl TJ; Chan MF
    Antimicrob Agents Chemother; 2002 May; 46(5):1262-8. PubMed ID: 11959554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
    Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
    J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A; Klesel N; Wollmann T; Isert D; Limbert M; Schrinner E; Seibert G; Bauernfeind A; Jungwirth R; Wilhelm R
    J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the new orally active cephalosporin FK027.
    Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H
    J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AmpC and AmpH, proteins related to the class C beta-lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli.
    Henderson TA; Young KD; Denome SA; Elf PK
    J Bacteriol; 1997 Oct; 179(19):6112-21. PubMed ID: 9324260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro investigation of BK-218, a new oral and parenteral cephalosporin.
    Szabó I; Barabás J; Tar A; Kiss L; Filep M; Schmidt T; Marossy K; Tóth-Martinez B; Barabás G; Hernádi F
    Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
    Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S
    J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of the dual-action cephalosporin Ro 23-9424.
    Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
    Maejima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).
    Williamson R; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1984 Dec; 14(6):581-93. PubMed ID: 6394571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
    Seefeld MA; Miller WH; Newlander KA; Burgess WJ; Payne DJ; Rittenhouse SF; Moore TD; DeWolf WE; Keller PM; Qiu X; Janson CA; Vaidya K; Fosberry AP; Smyth MG; Jaworski DD; Slater-Radosti C; Huffman WF
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2241-4. PubMed ID: 11527706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
    Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
    Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
    Heath RJ; Li J; Roland GE; Rock CO
    J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam.
    Chantot JF; Klich M; Teutsch G; Bryskier A; Collette P; Markus A; Seibert G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1756-63. PubMed ID: 1416860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.
    Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN
    Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.